Evidence map›Paper›PMID 37676902›Full record

ArticlePloS one2023

A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia.

Peter Seah Keng Tok, Li Ping Wong, Su May Liew, Asmah Razali, Mohd Ihsani Mahmood, Thilaka Chinnayah, Lisa Kawatsu, Haidar Rizal Toha, Khalijah Mohd Yusof, Rozanah Abd Rahman and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Peter Seah Keng TokInstitute for Clinical Research, National Institutes of Health (NIH), Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.ORCID 0000-0003-3663-450X
Li Ping WongCentre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Su May LiewDepartment of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Asmah RazaliSector of TB/Leprosy, Disease Control Division, Ministry of Health Malaysia, Putrajaya, Malaysia.
Mohd Ihsani MahmoodSector of TB/Leprosy, Disease Control Division, Ministry of Health Malaysia, Putrajaya, Malaysia.
Thilaka ChinnayahSector of TB/Leprosy, Disease Control Division, Ministry of Health Malaysia, Putrajaya, Malaysia.
Lisa KawatsuDepartment of Epidemiology and Clinical Research, the Research Institute of Tuberculosis, Japan Anti-tuberculosis Association (RIT/JATA), Tokyo, Japan.ORCID 0000-0003-2666-844X
Haidar Rizal TohaJohor State Health Department, Ministry of Health Malaysia, Johor Bahru, Johor, Malaysia.
Khalijah Mohd YusofJohor State Health Department, Ministry of Health Malaysia, Johor Bahru, Johor, Malaysia.
Rozanah Abd RahmanRespiratory Medicine Department, Hospital Sultanah Aminah, Ministry of Health Malaysia, Johor Bahru, Johor, Malaysia.ORCID 0009-0003-3459-0643
Shaharom Nor Azian Che Mat DinJohor State Health Department, Ministry of Health Malaysia, Johor Bahru, Johor, Malaysia.
Tharani LoganathanCentre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0001-6690-000X
Ministry of Health · MYUniversity of Malaya · MYJapan Anti Tuberculosis Association · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLoss to follow-up (LTFU) is an unsuccessful treatment outcome for tuberculosis (TB) patients. In Malaysia, LTFU affects around 1 in 20 TB patients. Integration of qualitative research methods and evidence will provide a better understanding of LTFU and its underlying issues. In this study, we qualitatively explored TB patients' experiences in receiving treatment and their reasons for leaving TB care.

methodIn-depth interviews of 15 patients with a history of LTFU were conducted from January to September 2020. Interview guides were developed to explore TB patients' experiences while receiving treatment, including challenges faced and reasons for treatment interruption. Data were thematically analysed using the framework method.

resultsWe identified 11 emerging themes that occurred at four levels of interaction with TB patients. First, at the patient personal level, TB beliefs referring to patients' perception of illness and wellness, patients' perceived role of traditional and complementary medicine, and substance abuse were important. Second, the healthcare system and treatment factors that were highlighted included the organisation of care and treatment, interaction with healthcare professionals, particularly in communication and counselling, and TB medications' side effects. Third, structural factors including financial burden, logistical and transportation issues and work-related factors were identified to be barriers to treatment continuation. Fourth, the interpersonal level interaction of patients should not be neglected; this includes family relationships and support as well as peer influence.

conclusionStudy findings put forth issues and challenges faced by TB patients while receiving treatment and underscore areas where actions can be taken. This will contribute to informing the development and implementation of future TB control strategies that are responsive to TB patients' needs and concerns, to effectively address LTFU and ensure better treatment completion rates among TB patients in Malaysia.

Indexed as

Drug-Related Side Effects and Adverse ReactionsLost to Follow-UpCommunicationFinancial StressHumansMalaysia

Identifiers

PMID37676902
PMCPMC10484432
OpenAlexW4386495413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.